Home » Topics » BioWorld Science

BioWorld Science
RSS

Collagen Corp. acquires distribution rights to Tissue Technologies' ePTFE implant

June 7, 1996

No Comments

Synthetic retinoid analogue cleared for U.S. market

June 7, 1996

No Comments

Pfizer reveals migraine treatment

June 7, 1996

No Comments

Oclassen obtains rights to 5-MOP

June 7, 1996

No Comments

Controlled-release oxycodone HCl now on U.S. shelves

June 7, 1996

No Comments

More tachykinin antagonists described by Merck & Co.

June 7, 1996

No Comments

Clinical trials on Diatide's Sn-117m DTPA

June 7, 1996

No Comments

Tachykinin NK1 antagonists described by Ciba-Geigy

June 7, 1996

No Comments

Protein farnesyltransferase inhibitor from Banyu and Merck & Co.

May 31, 1996

No Comments

Centocor's CenTNF sees positive results

May 31, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

BioWorld Science
RSS

Collagen Corp. acquires distribution rights to Tissue Technologies' ePTFE implant

Synthetic retinoid analogue cleared for U.S. market

Pfizer reveals migraine treatment

Oclassen obtains rights to 5-MOP

Controlled-release oxycodone HCl now on U.S. shelves

More tachykinin antagonists described by Merck & Co.

Clinical trials on Diatide's Sn-117m DTPA

Tachykinin NK1 antagonists described by Ciba-Geigy

Protein farnesyltransferase inhibitor from Banyu and Merck & Co.

Centocor's CenTNF sees positive results

Today's news in brief

Today's news in brief

Regulatory actions for Oct. 31, 2024

Nanocube’s nanorobots to revolutionize cancer diagnosis, treatment

Cureverse, Angelini ink $360M deal for oral Alzheimer’s drug

BioWorld Science RSS

BioWorld Science
RSS